Nora Wong

2.8k citations

41 papers · 1.7k indexed · h-index 20

Co-authors: William D. Foulkes Louis R. Bégin Pierre O. Chappuis Jean‐Sébastien Brunet John R. Goffin Nancy Hamel Linda Kapusta Ingunn M. Stefansson
Topics: BRCA gene mutations in cancer (25 papers)Cancer Genomics and Diagnostics (14 papers)Genetic factors in colorectal cancer (9 papers)
Cited by: Cancer Research Genetics Oncology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Oncology Cancer
Partner nations: Canada United States Norway

In The Last Decade

Nora Wong

39 papers receiving 1.7k citations

Peers

Countries citing papers authored by Nora Wong

Since Specialization

Citations

This map shows the geographic impact of Nora Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Wong more than expected).

Fields of papers citing papers by Nora Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Wong. The network helps show where Nora Wong may publish in the future.

Co-authorship network of co-authors of Nora Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Wong. A scholar is included among the top collaborators of Nora Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Wong. Nora Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age 2025 ·Annals of Surgical Oncology ·(unknown),(unknown),(unknown),(unknown),Mark Basik,Jean Francois Boileau,(unknown),Sarkis Meterissian,Nora Wong,Evan Weber,William D. Foulkes,(unknown),Stephanie M. Wong	0
2	Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatment 2025 ·Hereditary Cancer in Clinical Practice ·Stephanie M. Wong,(unknown),(unknown),(unknown),(unknown),Mark Basik,(unknown),Sarkis Meterissian,David Fleiszer,Nora Wong,(unknown),Talía Malagón,Jean Francois Boileau,William D. Foulkes	1
3	Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy 2024 ·European Journal of Surgical Oncology ·(unknown),(unknown),(unknown),(unknown),Mark Basik,Jean Francois Boileau,(unknown),Sarkis Meterissian,(unknown),Nora Wong,William D. Foulkes,Stephanie M. Wong	5
4	Pathologic complete response rates in BRCA1/2 and PALB2-associated breast cancer treated with neoadjuvant chemotherapy 2024 ·European Journal of Surgical Oncology ·(unknown),(unknown),(unknown),(unknown),Mark Basik,(unknown),Jean Francois Boileau,Sarkis Meterissian,Nora Wong,William D. Foulkes,Stephanie M. Wong	0
5	Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer 2023 ·Lung Cancer ·(unknown),Andreas I. Papadakis,Nora Wong,(unknown),(unknown),Tania Cruz Mariño,Pierre Fiset,William D. Foulkes	1
6	Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy 2023 ·Annals of Surgical Oncology ·(unknown),(unknown),(unknown),(unknown),Alex Viezel-Mathieu,Mark Basik,Jean Francois Boileau,Sarkis Meterissian,Nora Wong,William D. Foulkes,Stephanie M. Wong	1
7	Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated? 2022 ·Annals of Surgical Oncology ·Stephanie M. Wong,(unknown),(unknown),(unknown),(unknown),Mark Basik,Jean Francois Boileau,Sarkis Meterissian,Olga Aleynikova,Nora Wong,William D. Foulkes	11
8	No Evidence of Excessive Cancer Screening in Female Noncarriers from BRCA1/2 Mutation–Positive Families 2017 ·Current Oncology ·(unknown),(unknown),William D. Foulkes,Pavel Hamet,Jacques Simard,Nora Wong,(unknown),Jocelyne Chiquette,Michel Dorval	3
9	Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study 2013 ·Hereditary Cancer in Clinical Practice ·(unknown),(unknown),Carmen G. Loiselle,Nora Wong	7
10	Decision-Making Process of Women Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation Who Have Chosen Prophylactic Mastectomy 2010 ·Oncology nursing forum ·(unknown),(unknown),Carmen G. Loiselle,Nora Wong	17
11	A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers 2009 ·Annals of Oncology ·(unknown),Nora Wong,George Chong,(unknown),Gretchen Schneider,Beth Rosen‐Sheidley,William D. Foulkes,Marc Tischkowitz	24
12	Functional redundancy of exon 12 ofBRCA2revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant 2009 ·Human Mutation ·Lili Li,Kajal Biswas,(unknown),Sergey G. Kuznetsov,Nancy Hamel,Tomas Kirchhoff,Nora Wong,Susan Randall Armel,George Chong,Steven A. Narod,Kathleen Claes,Kenneth Offit,Mark E. Robson,Stacey Stauffer,Shyam K. Sharan,William D. Foulkes	26
13	Mixed Ovarian Germ Cell Tumor in a BRCA2 Mutation Carrier 2007 ·International Journal of Gynecological Pathology ·Nancy Hamel,Nora Wong,Lesley Alpert,(unknown),William D. Foulkes	6
14	The Value of Multi-Modal Gene Screening in HNPCC in Quebec: Three Mutations in Mismatch Repair Genes that would have not been Correctly Identified by Genomic DNA Sequencing Alone 2006 ·Familial Cancer ·(unknown),Lili Li,Isabelle Thiffault,Philip H. Gordon,Elizabeth MacNamara,Nora Wong,(unknown),Lidia Kasprzak,George Chong,William D. Foulkes	6
15	Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment 2005 ·Annals of Oncology ·Pierre O. Chappuis,(unknown),John R. Goffin,Nora Wong,L.R. Bégin,Linda Kapusta,Jean‐Sébastien Brunet,Peggy L. Porter,William D. Foulkes	39
16	A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment 2003 ·Breast Cancer Research ·Mark E. Robson,Pierre O. Chappuis,Jaya M. Satagopan,Nora Wong,Jeff Boyd,John R. Goffin,Clifford A. Hudis,David Roberge,Larry Norton,Louis R. Bégin,Kenneth Offit,William D. Foulkes	212
17	Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer 2003 ·British Journal of Cancer ·(unknown),Oddbjørn Straume,Pierre O. Chappuis,(unknown),(unknown),Nancy Hamel,Nora Wong,(unknown),William D. Foulkes	42
18	Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma 2003 ·Cancer ·John R. Goffin,Pierre O. Chappuis,Louis R. Bégin,Nora Wong,Jean‐Sébastien Brunet,Nancy Hamel,(unknown),Jeff Boyd,William D. Foulkes	80
19	Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families 2001 ·Diseases of the Colon & Rectum ·Rogério Rabelo,William D. Foulkes,Philip H. Gordon,Nora Wong,(unknown),Elizabeth MacNamara,George Chong,L. Pinsky,Dana D. Lasko	20
20	Isolation of Arabidopsis thaliana mutants hypersensitive to gamma radiation 1994 ·Molecular and General Genetics MGG ·Corinne S. Davies,(unknown),(unknown),Nora Wong	23

About Nora Wong

Nora Wong is a scholar working on Cancer Research, Genetics and Oncology, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (25 papers), Cancer Genomics and Diagnostics (14 papers) and Genetic factors in colorectal cancer (9 papers). The work is most often cited by research in Cancer Research (726 citations), Genetics (852 citations) and Oncology (638 citations). Nora Wong has collaborated with scholars based in Canada, United States and Norway. Frequent co-authors include William D. Foulkes, Louis R. Bégin, Pierre O. Chappuis, Jean‐Sébastien Brunet, John R. Goffin, Nancy Hamel, Linda Kapusta, Ingunn M. Stefansson, Lars A. Akslen and Steven A. Narod. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact